跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 325 条关于
“hyaluronidase-qvfc”
全部
325
临床试验
183
药物
38
机构
0
资讯
104
去年
VYVDURA Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
2年前
FDA Grants Accelerated Approval to Krazati Plus Cetuximab for KRAS G12C-Mutated Colorectal Cancer
2年前
VYVGART Hytrulo Approved by FDA as First FcRn Blocker for CIDP Treatment
10个月前
AstraZeneca's Gefurulimab Meets Phase III Endpoints in Myasthenia Gravis but Lags Behind Competitor Therapies
去年
Argenx Showcases Long-term Efficacy and Safety Data for VYVGART at AAN 2025 Meeting
7个月前
Hyaluronidase Co-Administration Enhances Cancer Immunotherapy Efficacy Through Subcutaneous Delivery
去年
Subcutaneous Immunoglobulin with Hyaluronidase Shows Promise for Idiopathic Inflammatory Myositis Treatment
9个月前
Huonslab Submits Biologics License Application for Recombinant Human Hyaluronidase HYDIZYME™
去年
Huonslab Secures Key Patent for Albumin-Free Hyaluronidase Formulation, Advances Toward 2026 Market Authorization
9个月前
Celltrion Internalizes Hyaluronidase-Based Subcutaneous Formulation Technology to Expand Biosimilar Pipeline
第 1 页,共 11 页
上一页
下一页